Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for the Wiskott-Aldrich Syndrome

Trial Profile

Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for the Wiskott-Aldrich Syndrome

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 03 Feb 2017

At a glance

  • Drugs WASp gene therapy (Primary)
  • Indications Wiskott-Aldrich syndrome
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 31 Jan 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Jul 2017.
    • 31 Jan 2017 Status changed from recruiting to active, no longer recruiting.
    • 07 Nov 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Apr 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top